Unani Medicine: Significance of Asbab-e-Sitta Zarooriya in times of Pandemic COVID-19

  • Araf Fatma PG Scholar, Department of Tahaffuzi-wa-Samaji Tibb, School of Unani Medical Education and Research, Jamia Hamdard, New Delhi, India
  • Aisha Perveen Assistant Professor, Department of Tahaffuzi-wa-Samaji Tibb, School of Unani Medical Education and Research, Jamia Hamdard, New Delhi, India
  • Sana Ur Rehman PG Scholar,  Department of Tahaffuzi-wa-Samaji Tibb, School of Unani Medical Education and Research, Jamia Hamdard, New Delhi, India
  • Rabia Khan PG Scholar, Department of Moalijat, School of Unani Medical Education and Research, Jamia Hamdard, New Delhi, India

Abstract

SARS COV-2 belongs to the beta coronavirus genera, it is believed that bats as warm-blooded flying vertebrates are ideal hosts for coronavirus gene source. COVID-19 caused by novel coronavirus was originated from Wuhan city of Hubei Province in China in December 2019. The common symptoms comprise fever, cough, malaise, and shortness of breath. The incubation period is between  2 - 14 days. In this paper we have deliberated the structure of viruses; varying symptoms among COVID-19, SARS, MERS, and approach to tackling this problem with utmost effective Unani alternatives. Unani medicine endeavors to find the best conceivable ways by which a person can lead a hale and hearty life with minimum or zero sicknesses. Unani scholars believe by practicing important things like the use of fresh and clean water, breathing clean air and eating fresh food, upholding a balance between the mind and the body so that the metabolic processes can function effortlessly and the body wastes are evacuated, by enhancing immunity, and keeping an equilibrium between (Asbab-e-Sitta Zarooriya) six essential factors for life one can stay away from diseases.


Keywords: COVID-19, Unani Medicine, SARS COV-2, Asbab-e-Sitta Zarooriya.

Keywords: COVID-19, Unani Medicine, SARS COV-2, Asbab-e-Sitta Zarooriya

Downloads

Download data is not yet available.

Author Biographies

Araf Fatma, PG Scholar, Department of Tahaffuzi-wa-Samaji Tibb, School of Unani Medical Education and Research, Jamia Hamdard, New Delhi, India

PG Scholar,  Department of Tahaffuzi-wa-Samaji Tibb, School of Unani Medical Education and Research, Jamia Hamdard, New Delhi, India

Aisha Perveen, Assistant Professor, Department of Tahaffuzi-wa-Samaji Tibb, School of Unani Medical Education and Research, Jamia Hamdard, New Delhi, India

Assistant Professor,  Department of Tahaffuzi-wa-Samaji Tibb, School of Unani Medical Education and Research, Jamia Hamdard, New Delhi, India

Sana Ur Rehman, PG Scholar,  Department of Tahaffuzi-wa-Samaji Tibb, School of Unani Medical Education and Research, Jamia Hamdard, New Delhi, India

PG Scholar,  Department of Tahaffuzi-wa-Samaji Tibb, School of Unani Medical Education and Research, Jamia Hamdard, New Delhi, India

Rabia Khan, PG Scholar, Department of Moalijat, School of Unani Medical Education and Research, Jamia Hamdard, New Delhi, India

PG Scholar, Department of Moalijat, School of Unani Medical Education and Research, Jamia Hamdard, New Delhi, India

References

1. Romanov BK. Coronavirus disease COVID-2019. Safety and Risk of Pharmacotherapy. 2020; 8(1): p. 3-8.
2. WHO. Naming the coronavirus disease (COVID-19) and the virus that causes it. ; on 28.2.2020.
3. en.nhc.gov.cn. A daily briefing on novel coronavirus cases in China. ; 7 Feb 2020.
4. Campbell C. “The Wuhan Pneumonia crisis highlights the danger in china’s opaque way of doing things”. ; time retrieved 13 march 2020.
5. Vohora SB. Unani Joshandah Drugs for Common Cold, Catarrh, Cough, and Associated Fevers. Journal of Ethnopharmacology. 1986; 16(2-3): p. 201-202.
6. Cagno Vea. Ficus Religiosa L. Bark Extracts Inhibit Human Rhinovirus and Respiratory Syncytial Virus Infection in Vitro. Journal of Ethnopharmacology. 2015; 176: p. 252–5.
7. Kabiruddin A. Tarjuma wa shrah Kulliyate Qanoon Delhi: Idara Kitab Ush Shifa; 1999.
8. Kabiruddin A. Tarjuma wa Shrah Kulliyate Nafisi Delhi: Idara Kitab Ush Shifa; 2009.
9. Water transmission and Covid-19. ; Accessed, 19 March 2020.
10. Ali I, Alharbi ML. COVID-19: Disease, Management, Treatment, and Social Impact. Science of the Total Environment. 2020; 728: p. 138861.
11. Guo YR, Hong ZS. The origin, transmission, and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak- An update on the status. Military Medical Research. Military Medical Research. 2020; 7(1): p. 1-10.
12. Hui SC, Zumla. Severe Acute Respiratory Syndrome: Historical, Epidemiologic, and Clinical Features. Infectious Disease Clinics of North America. Elsevier Inc. 2019; 34(4): p. 869–889.
13. Zheng Jea. Middle East respiratory syndrome coronavirus seropositivity in camel handlers and their families, Pakistan. Emerging Infectious Diseases. 2019; 25(12): p. 2307–2309. DOI: 10.3201/eid2512.191169.
14. Chen Nea. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study’ 395(10223). The Lancet. Elsevier Ltd. 2020; 395(10223): p. 507–513.
15. Sonja A. Rasmussen AKWDLS. Middle East Respiratory Syndrome (MERS) Washington DC: ASM Press; 2016.
16. WHO. Q&A on coronaviruses (COVID-19). ; 11 March 2020.
17. WHO. Q&A on coronaviruses (COVID-19). ; 2020.
18. Cao , Li T, Liang L. Clinical characteristics of Coronavirus Disease 2019 patients in Beijing, China. PLOS ONE.
19. Huang C, Wang Y, Li X, al. e. Clinical features of patients. Lancet. 2020; 395(10223): p. 497-506.
20. F. CDC test for 2019-nCoV. Archived from the original on 14 Feb 2020.
21. Wang Qea. MERS-CoV spike protein: Targets for vaccines and therapeutics. Antiviral Research. Elsevier B.V. 2016; 133: p. 165–177.
22. Nikhat S, Fazil M. Overview of Covid-19; its prevention and management in the light of Unani medicine. Science of the Total Environment. Elsevier B.V. 2020; 728: p. 138859.
23. Jean SS, Lee PI, Hsuehd PR. Treatment options for COVID-19: The reality and challenges. Journal of Microbiology, Immunology and Infection. Elsevier Taiwan LLC. 2020; 53(3): p. 436–443.
24. AYUSH D. Government of Uttar Pradesh, Covid-19, Paramarsh..
25. Advisory for Corona virus, Unani medicine useful in symptomatic management of corona virus. ; 2020.
26. LONE A, AHMAD , ANWAR , SOFI , IMAM. Perception of health promotion in Unani herbal medicine. J ournal of Herbal Medicine. Elsevier GmbH. (no date); 2(1): p. 1–5.
27. Razi Z. Kitab Al-Mansoor New Delhi: Central Council for Research in Unani Medicine. Ministry of Health and Family Welfare; 1991.
28. Nasiruddin , Zulkifle , Khan. Asbab-e-Sitta Zaruriyya ( six essential factors ): An Unique tool for the maintenance of human health. 2015; 3(4): p. 22–24.
29. Alig FA. Six essential factors and health. 2019; 3(1): p. 29-36.
30. Nigar Z. Unani Concept of Prevention and Control of Lifestyle Disorders : A Literature Unani Concept of Prevention and Control of Lifestyle Disorders : A Literature Review. 2020 May.
31. Rushd I. Kitab al-kulliyat: Urdu Trans; 1987.
32. Rushid. Kitab ul Kulliyat Delhi: CCRUM; 1987.
33. Sina I. Al qanoon fil tib Lucknow: Munshi Nawal Kishore; 1878.
34. Razi Z. Kitab al Hawi New Delhi: CCRUM; 2008.
35. H, Nazli , Grover , Kishore. Covid 19 Pandemic and “ Feeling Depressed ”: An Online Survey. 2020; 5(2): p. 27–31.
36. Ayush Do. Government of Uttar Pradesh, Covid-19, Paramarsh. [Online].
Statistics
293 Views | 276 Downloads
How to Cite
1.
Fatma A, Perveen A, Rehman SU, Khan R. Unani Medicine: Significance of Asbab-e-Sitta Zarooriya in times of Pandemic COVID-19. JDDT [Internet]. 15Jan.2021 [cited 22Sep.2021];11(1):156-61. Available from: https://jddtonline.info/index.php/jddt/article/view/4636